Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Hyperammonemia Management

Introduction

  • Hyperammonemia is a life-threatening condition that requires prompt diagnosis and treatment, with the goal of reducing blood ammonia levels and preventing neurological damage, as recommended by the European Society of Intensive Care Medicine 1

Dialysis Methods

  • High-dose CVVHD (continuous venovenous hemodialysis) is recommended as first-line treatment for hyperammonemic patients, providing more stable clearance with less rebound hyperammonemia compared to HD, according to the Nature Reviews Nephrology 1
  • Continuous Kidney Replacement Therapy (CKRT) is effective in rapidly reducing blood ammonia levels in hyperammonemic patients, and is associated with less rebound compared to HD due to its continuous nature 1
  • Peritoneal Dialysis (PD) is less effective than HD or CKRT but can still reduce ammonia levels, and may be used when vascular access is difficult 1
  • Hemodialysis can decrease blood ammonia by 75% within 3-4 hours, and is indicated for rapidly deteriorating neurological status, coma or cerebral edema, ammonia levels >1,000 μmol/L, and failure to respond to pharmacological therapy 1

Dialysis Prescription and Timing

  • For levels >400 μmol/L refractory to medical management, initiate CKRT, and switch from HD to CKRT once ammonia levels are <200 μmol/L on two consecutive hourly measurements 1
  • CKRT should be used with high-dose CVVHD with blood flow (Qb) 30-50 ml/min and dialysate flow/blood flow ratio (Qd/Qb) >1.5 1
  • Early initiation of dialysis is crucial, as the duration of hyperammonemic coma is a key prognostic factor 1
  • The following conditions require initiation of CKRT:

    | Condition | Blood Ammonia Level | Treatment | | --- | --- | --- | | Rapidly deteriorating neurological status | >150 μmol/L | Initiate CKRT | | Coma or cerebral edema | >150 μmol/L | Initiate CKRT | | Moderate or severe encephalopathy | >400 μmol/L | Initiate CKRT | | Rapid rise in blood ammonia levels | >300 μmol/L | Initiate CKRT | | Rebound hyperammonemia | - | Continue nitrogen-scavenging agents during dialysis | 1

Patient Considerations

  • Vascular access is required for CKRT, which may be challenging in neonates 1
  • CKRT provides better hemodynamic stability than HD, especially important in critically ill patients 1
  • Warming the dialysate helps maintain hemodynamic stability, particularly in neonates 1
  • Malnutrition is common and associated with poor prognosis in alcoholic hepatitis, and patients should receive adequate calories (35-40 kcal/kg of body weight daily) 2
  • Consider tube feeding if oral intake is inadequate in patients with liver disease 2

Medications and Supplements

  • Rifaximin may be added to lactulose for treatment of hepatic encephalopathy in patients with liver disease 2
  • Sodium benzoate dosage is based on body weight, with 250 mg/kg for body weight <20 kg and 5.5 g/m² for body weight >20 kg, given over 90 min as bolus then as maintenance over 24 hours, with a maximum dose of 12 g daily, as recommended by the American Association for the Study of Liver Diseases 1
  • Sodium phenylacetate dosage is also based on body weight, with 250 mg/kg for body weight <20 kg and 5.5 g/m² for body weight >20 kg, given over 90 min as bolus then as maintenance over 24 hours, as recommended by the American Association for the Study of Liver Diseases 1
  • L-arginine hydrochloride is used for urea cycle disorders, with specific dosages based on the type of deficiency and patient weight, as recommended by the American College of Physicians 1
  • Alcohol abstinence is the cornerstone of therapy for patients with alcoholic hepatitis, and supplementing with B-complex vitamins can prevent Wernicke's encephalopathy 2
  • Avoid nephrotoxic drugs and diuretics to prevent acute kidney injury in patients with liver disease, and avoid beta-blockers in patients with severe alcoholic hepatitis as they may increase the risk of acute kidney injury 2

Monitoring and Prognosis

  • Measure ammonia levels and assess neurological status using the Glasgow Coma Scale in patients with suspected hyperammonemia, as recommended by the European Society of Intensive Care Medicine 1
  • Check ammonia levels at 24 hours and 5-7 days, and monitor neurological status, as recommended by the American Association for the Study of Liver Diseases 1
  • The duration of hyperammonemic coma and plasma ammonia levels are key prognostic factors, with adverse prognostic factors including hyperammonemic coma lasting >3 days, increased intracranial pressure, and plasma ammonia level >1,000 μmol/L, as recommended by the European Society of Intensive Care Medicine 1
  • The following clinical scenarios require recommended actions:

    | Clinical Scenario | Ammonia Level | Recommended Action | |-------------------|---------------|-------------------| | Rapidly deteriorating neurological status | >150 μmol/L | Initiate CKRT | | Moderate/severe encephalopathy | Any level | Consider treatment | | Persistently high levels | >400 μmol/L | Initiate CKRT if refractory to medical management | | Rapid rise in levels | >300 μmol/L | Initiate CKRT if uncontrolled by medical therapy | 3

Supportive Care

  • Ensure adequate volume replacement and maintain mean arterial pressure, as suggested by a medical guideline society, and use vasopressors (dopamine, epinephrine, norepinephrine) as needed, correcting electrolyte abnormalities, particularly glucose, potassium, magnesium, and phosphate, as recommended by a medical society 4, 5
  • Treat acid-base disturbances, and consider high-dose vitamin D3 supplementation in critically ill patients with measured low levels, as suggested by a medical guideline society, and administer vitamin K (at least one dose) in coagulopathic patients, performing surveillance for infections (common trigger for encephalopathy) 6, 4
  • Administer appropriate antibiotics promptly when infection is identified, and consider antibiotic prophylaxis in high-risk patients, as suggested by a medical guideline society 7, 4